🔗 Share this article

An underground market for unapproved slimming medications is being driven by TikTok fitness influencers and sellers on communication apps, based on new investigations.

Experimental Treatment Gaining Traction Online

The experimental drug, which remains in clinical trials, is being advertised by online personalities for its alleged fat-burning effects. Viewers are urged to message these profiles directly for source information, while also receiving discount codes.

Thriving Trade on Messaging Platforms

Separately, a flourishing market exists on messaging services, where groups with numerous of participants share comparison images, administration instructions and assertions of rapid UK delivery. Sellers promote the drug there before directing buyers to WhatsApp for purchases.

Understanding The Experimental Drug

This medication is an experimental injection developed by US drugmaker Eli Lilly. The drug targets three gut hormones – GLP-1, GIP and glucagon. Preliminary studies indicate it could assist patients lose up to a quarter of their body weight. Referred to as the “triple G”, the drug is being promoted online as the successor to Ozempic.

Medical Experts Express Concerns

However, physicians and chemists have cautions that the sale of what remains an unapproved medication in the UK is a cause for concern and could result in users administering products of unknown origin.

Several experts said the popularity for retatrutide could be connected to the increasing price of approved weight loss treatments such as Mounjaro.

Regulatory Position and Enforcement

Marketing retatrutide on TikTok or messaging apps is illegal in the UK, as it is an unlicensed medication that must not be marketed or supplied for personal consumption under the British medical regulations.

Some influencers attempt to sidestep the regulations by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but advertising and distribution can still violate medicines, marketing, and consumer regulations, potentially leading to fines, legal action or imprisonment.

Platform Reaction and Content Removal

According to the social media company, the service has taken down problematic material and prohibited related hashtags and search suggestions. The company said it was dedicated to maintaining the platform secure and allocating resources in enhancing compliance measures.

Online Trading Activities

Research also discovered groups with up to nine thousand members selling the experimental drug using Telegram's integrated discovery tool, which operates like a public directory. Typing “retatrutide” instantly brings up channels with numerous of users, filled with photos of slimming results, positive testimonials and detailed guides for preparing or administering at residence.

After minutes of entering one community, a vendor posted WhatsApp details, where the majority of transactions take place. The seller provided an instruction manual and promised delivery within 48 hours. When questioned whether the substance was authentic, one seller responded: “You can’t be sure.” Another provided a photo of a supposed laboratory certificate. None asked about weight, health issues or previous experience.

Item Details and Pricing

Inside these groups, messages display black plastic parcels with postal service stickers, stating to include fresh supplies. One communication stated: “It took eight of us to load them this morning.”

Buyers can select between powder vials, prepared at home with sterile water, or ready-to-use pens usually priced at £160 for 20mg. When asked how long a pen should be used, sellers give conflicting responses ranging from a several days to “depends on your body”.

Service Moderation and Safety Actions

A representative for the messaging service said it regularly moderated harmful material on its platform including content that promoted the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.

Medical Professional Warnings

“Individuals are administering substances they can’t verify. Although the research behind retatrutide is sound, these online versions may not include what they advertise,” stated Jason Murphy, the director of pharmacy at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor linked the increase in demand to current cost increases for approved weight-loss medications such as Mounjaro. “With costs rising, individuals are using online platforms. But counterfeit injections are highly risky. You cannot know what’s inside or whether the conditions they were produced in was sterile,” she said.

Her team has previously encountered patients harmed by self-injection from unconfirmed suppliers. “We recognize the disappointment, but buying from Telegram or WhatsApp is taking chances with your health,” stated Wyllie. “These substances could be impure or incorrectly dosed.”

Producer Position

A representative from the pharmaceutical company said the substance was in third stage research studies and had not been reviewed or authorized by any regulatory agency anywhere in the world. “Therefore at this point no one can market [it] for human use,” they said, adding that any product “falsely representing itself as a Lilly experimental product not yet approved … may expose patients to possibly serious medical dangers”.